{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:32:30Z","timestamp":1790836350212,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003776","name":"Newcastle upon Tyne Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000774","name":"Newcastle University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background &amp; Aims<\/jats:title><jats:p>Rifaximin\u2010\u03b1 reduces the risk of recurrence of overt hepatic encephalopathy. However, there remain concerns regarding the financial cost of the drug. We aimed to study the impact of treatment with rifaximin\u2010\u03b1 on healthcare resource utilisation using data from seven UK liver treatment centres.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All seven centres agreed a standardised data set and data characterising clinical, demographic and emergency hospital admissions were collected retrospectively for the time periods 3, 6 and 12 months before and following initiation of rifaximin\u2010\u03b1. Admission rates and hospital length of stay before and during therapy were compared. Costs of admissions and drug acquisition were estimated using published sources. Multivariate analyses were carried out to assess the relative impact of various factors on hospital length of stay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Data were available from 326 patients. Following the commencement of rifaximin, the total hospital length of stay reduced by an estimated 31\u201353%, equating to a reduction in inpatient costs of between \u00a34858 and \u00a36607 per year. Taking into account drug costs of \u00a33379 for 1\u2010year treatment with rifaximin\u2010\u03b1, there was an estimated annual mean saving of \u00a31480\u2013\u00a33228 per patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Initiation of treatment with rifaximin\u2010\u03b1 was associated with a marked reduction in the number of hospital admissions and hospital length of stay. These data suggest that treatment of patients with rifaximin\u2010\u03b1 for hepatic encephalopathy was generally cost saving.<\/jats:p><\/jats:sec>","DOI":"10.1111\/liv.13111","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T15:02:39Z","timestamp":1457362959000},"page":"1295-1303","source":"Crossref","is-referenced-by-count":48,"title":["The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin\u2010\u03b1"],"prefix":"10.1111","volume":"36","author":[{"given":"James G.","family":"Orr","sequence":"first","affiliation":[{"name":"Liver Unit Freeman Hospital Newcastle upon Tyne UK"},{"name":"Institute of Cellular Medicine Newcastle University Newcastle upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Currie","sequence":"additional","affiliation":[{"name":"Cochrane Institute School of Medicine Cardiff University Cardiff UK"},{"name":"Pharmatelligence Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Berni","sequence":"additional","affiliation":[{"name":"Pharmatelligence Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Goel","sequence":"additional","affiliation":[{"name":"Gastroenterology Royal Bolton Hospital Bolton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran J.","family":"Moriarty","sequence":"additional","affiliation":[{"name":"Gastroenterology Royal Bolton Hospital Bolton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Sinha","sequence":"additional","affiliation":[{"name":"Liver Unit Bristol Royal Infirmary Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gordon","sequence":"additional","affiliation":[{"name":"Liver Unit Bristol Royal Infirmary Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dethier","sequence":"additional","affiliation":[{"name":"Gastroenterology Ninewells Hospital Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Dillon","sequence":"additional","affiliation":[{"name":"Gastroenterology Ninewells Hospital Dundee UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Clark","sequence":"additional","affiliation":[{"name":"Gastroenterology The Royal Liverpool University Hospital Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Richardson","sequence":"additional","affiliation":[{"name":"Gastroenterology The Royal Liverpool University Hospital Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Middleton","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies and Transplantation King's College London School of Medicine King's College Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Patel","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies and Transplantation King's College London School of Medicine King's College Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Shawcross","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies and Transplantation King's College London School of Medicine King's College Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Preedy","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Queen Alexandra Hospital Portsmouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Aspinall","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Queen Alexandra Hospital Portsmouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hudson","sequence":"additional","affiliation":[{"name":"Liver Unit Freeman Hospital Newcastle upon Tyne UK"},{"name":"Institute of Cellular Medicine Newcastle University Newcastle upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.31250"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23216"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00129-5"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024784327783"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23500"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5089-0"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.042"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907893"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04808.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.08.041"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03464.x"},{"key":"e_1_2_8_13_1","unstructured":"Anon.Hepatic encephalopathy (maintenance treatment) \u2013 rifaximin: appraisal consultation 2 document information.201327\/11\/2013; Available at:http:\/\/www.nice.org.uk\/guidance\/gid-tag297\/documents\/hepatic-encephalopathy-maintenance-treatment-rifaximin-appraisal-consultation-2-document. [cited 2015 20\/01\/2015]."},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(14)60640-1"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.05.016"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61930-3"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5852"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817"},{"key":"e_1_2_8_19_1","unstructured":"NHS reference costs.https:\/\/www.gov.uk\/government\/publications\/nhs-reference-costs-2013-to-2014 2013\u201314."},{"key":"e_1_2_8_20_1","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2015"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9442-4"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03958.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3182506dbb"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.157"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1746-6342.2006.03215.x"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.13111","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.13111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.13111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:33:03Z","timestamp":1695504783000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.13111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1111\/liv.13111"],"URL":"https:\/\/doi.org\/10.1111\/liv.13111","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]}}}